Skip to main navigation Skip to search Skip to main content

PIB: A score to select sorafenib treatment candidates for hepatocellular carcinoma in resource-limited settings

  • James S. Leathers
  • , Domingo Balderramo
  • , Jhon Prieto
  • , Fernando Diehl
  • , Esteban Gonzalez-Ballerga
  • , Melina R. Ferreiro
  • , Enrique Carrera
  • , Fernando Barreyro
  • , Javier Diaz-Ferrer
  • , Dupinder Singh
  • , Angelo Z. Mattos
  • , Flair Carrilho
  • , Jose D. Debes

Research output: Contribution to journalOriginal Articlepeer-review

1 Scopus citations
Original languageAmerican English
Article numbere82345
JournalHepatitis Monthly
Volume18
Issue number10
DOIs
StateIndexed - Oct 2018
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • HCC
  • Hepatocellular carcinoma
  • Score
  • Sorafenib

Cite this